Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:00:00 on US and Canada Markets.
R evolution Medicines Expect s to Conduct Late-Stage Development of RAS(ON) I nhibitor Drug C andidate Pipeline Supported by Fortified Balance Sheet Agreement is the Result of a Rigorous Process Conducted by Independe...
Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that the C...
HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2024 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 23% AND ASSETS UNDER MANAGEMENT GROWING BY 8% YEAR-OVER-YEAR HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2024 RESULTS, WITH MANAGEMENT & ADVISORY FEES GRO...
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 PR Newswire Conference call scheduled for 9:00 AM ET ...
Total deal size of approximately ~$650M, including over $150M in upfront and near-term milestones Neuraxpharm’s dedicated neurology focus and established European presence makes them an attractive partner for BRIUMVI’s European launch, targeted within the next six months ...
SiriusXM Reports Second Quarter 2023 Operating and Financial Results PR Newswire NEW YORK , Aug. 1, 2023 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today reported operating and financial results for the second quarter 2023, which have been posted to the Investor Rel...
TARRYTOWN, N.Y., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 11th annual Regeneron Prize for Creative Innovation, a competition designed to honor exceptional talent and originality in biomedical research. Each year, Regeneron...
Agreement provides ProQR with initial payment of €12.5M and up to €135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU Divestment of sepofarsen and ultevursen supports ProQR’s strategic focus on the Axiomer&...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 3:00 p.m. ET. An audio webcast of the presentation will be available...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on August 8, 2023 at 8:30 a.m. ET to discuss second quarter results and provide a general business update. To access the con...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.17%Change Percent:
LivePerson Inc. Company Name:
LPSN Stock Symbol:
NASDAQ Market:
liveperson.com Website: